eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems. A royal commission, entitled The Royal Commission Appointed to Inquire into the Relations of Human and Animal Tuberculosis, was set up in 1901. It aimed to find out whether tuberculosis in animals and humans was the same disease and whether animals and humans could infect each other. This page describes how, by 1919, the Commission had evolved into the independent Medical Research Council.

Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand.

NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand.

Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells. The company was founded in July 2000 as Avicore Biotechnology Research Center and merged with Medipig Korea and Optipharm Solution Center in December 2007, after which it was renamed Optipharm Solution. It entered the veterinary medicine field in April 2008 by acquiring Farmscare, and it was listed on the KOSDAQ in October 2018 after the company's name was changed to its current name Optipharm in September 2012. It is currently involved in the business of animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, and so on, and it is expanding into the field of human medicine based on the technology that it has accumulated in the field of animal medicine.

METAFORA Biosystems SAS is a company headquartered in Paris, France. The firm operates as a biotechnology company. Romain Kaspereit is the current CEO of the firm.\nThe company says this about itself: METAFORA biosystems has developed METAflow, a flow cytometry data analysis software with unmatched robustness and a user-friendly interface that yields objective, reproducible, and actionable results from the increasingly large and unwieldy data sets generated by conventional, mass or spectral cytometry. METAflow in combination with Metafora?s proprietary reagents underpins METAbolism, the company?s IVD activity. METAglut1 is a first diagnostic test for the early diagnosis of De Vivo disease, a rare pediatric neurometabolic disorder. The company is developing a number of oncology diagnostics as well as a solution to increase the clinical efficacy of cell therapies and reduce manufacturing costs.

Beijing Geland Biotechnology Co., Ltd., established on 2015-04-01, Business scope includes technical promotion services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Computer System Services;software development;selling computers,Software and Auxiliary Equipment,medical instruments(limitIkind);retail chemical products(Free of Hazardous Chemicals),Equipment;Technology Import and Export,Import and export,Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

ToolGen, a biotechnology company, focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified that provides ready-to-use reagents for genome engineering experiments; gRNA/Cas9 plasmid that offers tools for genome editing experiment; and recombinant Cas9 protein that offers ready-to-use reagents for genome engineering experiments. ToolGen also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services. Its products are used in research applications. ToolGen began operation in 1999, with its headquarters in Seoul in South Korea. ToolGen is a subsidiary of NSN.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.

Revivicor is a regenerative medicine company focused on applying leading-edge animal biotechnology platforms to provide a superior quality, high-volume, human-compatible, alternative tissue source for treatment of human degenerative disease.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.

Shanghai Organ Diagnostic Technology Co., Ltd., established on 2018-08-28, The scope of business includes engaging in diagnostic technology,computer technology,Technology development in the field of medical technology,Technical Services,technical consulting,technology transfer,medical instruments,laboratory equipment,water treatment equipment,hardware tools,Optical Instruments,Wire and Cable,plastic products,Sales of electronic equipment,Maintenance of computer information systems,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hangzhou Shilun Pharmaceutical Technology Co., Ltd., established on 2019-05-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);New material technology promotion service;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Development of Human Gene Diagnosis and Therapy Technology;hospital management;Pension Service;internet sales(Except for products that require a license for sale);Cosmetics Retail;Personal Hygiene Sales;Cosmetics Wholesale;Sales of hygiene products and single-use medical products;Medical Research and Experimental Development;R&D and application of cell technology;Biochemical product technology research and development;Maternal and infant life care(Does not include medical services);Nursing facility services(Does not include medical services);Import and export;Food Internet Sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Technology Import and Export;Natural science research and experimental development;Agricultural Science Research and Experimental Development;Traditional Chinese Medicine Health Care Services(non-medical);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engage in investment activities with own funds;internet data service;Technology intermediary service;sales agent;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Inspection and testing service;Internet information service;Food Internet Sales;food sales;Internet live broadcast technology service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).